BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32311888)

  • 41. [Outcome of patients with adult acute lymphoblastic leukemia between 2000 and 2013: experience from single center].
    Wang J; Jiang B; Liu K; Xu L; Zhang X; Chen H; Jia J; Yang S; Bao L; Jiang H; Lu J; Zhu H; Zhao T; Huang X; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):726-32. PubMed ID: 26462770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation].
    Zou D; Huang W; Liu H; Fu M; Li Z; Sui W; Qi J; Zhao Y; Ru K; Han M; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):455-9. PubMed ID: 26134007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lyu M; Jiang E; He Y; Yang D; Ma Q; Pang A; Zhai W; Wei J; Huang Y; Zhang G; Zhang R; Feng S; Han M
    Hematology; 2021 Dec; 26(1):65-74. PubMed ID: 33402056
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effects of Pre-Transplant CONUT and Post-Transplant MRD on Prognosis of Patients with Multiple Myeloma after Auto-HSCT].
    Xiong YY; Zhou Q; Chen L; Yu W; Zhang HB; Chen JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):146-154. PubMed ID: 38387913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
    Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors of lymphoma patients after autologous stem cell transplantation.
    Qian F; Fan W; Wei X; Zhu Y; Fu G; Qin D; Tian X; Pei L; Xu S; Chen J; Zhang Y
    Ann Transplant; 2015 Apr; 20():225-32. PubMed ID: 25903985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma.
    Bersvendsen H; Kolstad A; Blystad AK; Aurlien E; Fosså A; Kvaløy SO; Holte H; Lauritzsen GF
    Acta Oncol; 2014 May; 53(5):680-7. PubMed ID: 24237392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrospective analysis of the efficacy and influencing factors of autologous hematopoietic stem cell transplantation for multiple myeloma.
    Zhang BL; Zhou J; Lin QD; Liu YZ; Zhang YL; Gui RR; Song YP; Fang BJ
    Artif Organs; 2019 Oct; 43(10):1028-1034. PubMed ID: 30972806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation].
    Ai H; Yin QS; Wang Q; Fu YW; Wei XD; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):239-244. PubMed ID: 32311895
    [No Abstract]   [Full Text] [Related]  

  • 51. [Autologous hematopoietic stem cell transplantation for patients with diffuse large B-cell lymphoma: a retrospective study].
    Lu XL; Li Y; Huang WR; Guo YL; Zhao XL; Lu N; Zhu HY; Wang QS; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):617-22. PubMed ID: 23815909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Autologous hematopoietic stem cell transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: a single center experience from the BDHALL2000/02 protocol].
    Wang T; Zou D; Zhang Y; Li Z; Sui W; Fu M; Zhao Y; Wang J; Mi Y; Feng S; Han M; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):480-4. PubMed ID: 26134012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Efficacy of Activated Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia].
    Ren RR; Ma LM; Wang T; Xie YX; Zhu QJ; Gao ZL; Tian WW; Gong R; Niu YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1509-1515. PubMed ID: 37846709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparative analysis between autologous and allogeneic hematopoietic stem cell transplantation in 114 adult patients with acute lymphoblastic leukemia in long-term follow-up].
    Bao YS; Jiang EL; Wang M; Wang H; Huang Y; Wei JL; Yang DL; Feng SZ; Qiu LG; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1325-9. PubMed ID: 19099637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of T Cell Lymphoblastic Lymphoma - Clinical observation of 10 Cases].
    Gong F; Chen H; Zhao LY; Wang T; Zhang R; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1759-1763. PubMed ID: 28024490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison of outcomes of adult acute lymphoblastic leukemia patients underwent autologous and allogeneic hematopoietic stem cell transplantation].
    Shen Y; Chen S; Yang D; He Y; Jiang E; Wei J; Huang Y; Zhang R; Ma Q; Pang A; Yang X; Wang Z; Cui J; Zhou L; Chen X; Feng S; Han M
    Zhonghua Xue Ye Xue Za Zhi; 2015 Mar; 36(3):210-5. PubMed ID: 25854464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-CD19 chimeric antigen receptor-modified T-cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia: An open-label pragmatic clinical trial.
    Jiang H; Li C; Yin P; Guo T; Liu L; Xia L; Wu Y; Zhou F; Ai L; Shi W; Lu X; Wang H; Tang L; Wei Q; Deng J; Jin R; Xiong W; Dong J; Mei H; Hu Y
    Am J Hematol; 2019 Oct; 94(10):1113-1122. PubMed ID: 31321805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.
    Nademanee A; Molina A; Dagis A; Snyder DS; O'Donnell MR; Parker P; Stein A; Smith E; Planas I; Kashyap A; Spielberger R; Fung H; Krishnan A; Bhatia R; Wong KK; Somlo G; Margolin K; Chow W; Sniecinski I; Vora N; Slovak M; Niland JC; Forman SJ
    Clin Lymphoma; 2000 Jun; 1(1):46-54. PubMed ID: 11707813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
    Kebriaei P; Bassett R; Lyons G; Valdez B; Ledesma C; Rondon G; Oran B; Ciurea S; Alousi A; Popat U; Patel K; Ahmed S; Olson A; Bashir Q; Shah N; Jones R; Marin D; Rezvani K; Nieto Y; Khouri I; Qazilbash M; Hosing C; Shpall E; Champlin RE; Andersson BS
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):285-292. PubMed ID: 27816651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline Therapy for Intermediate/High-risk Diffuse Large B Cell Lymphoma.
    Wen Q; Gao L; Xiong JK; Li Q; Wang SB; Wang JS; Liu F; Zhang C; Liu Y; Kong PY; Peng XG; Rao J; Gao L; Zhang X
    Curr Med Sci; 2021 Jun; 41(3):465-473. PubMed ID: 34218355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.